Vigilare Wealth Management Iovance Biotherapeutics, Inc. Transaction History

Vigilare Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$12.38 - $19.1 $148,250 - $228,722	-11,975 Closed	0 $0
Q4 2021 Jan 07, 2022	SELL	$16.55 - $27.63 $156,480 - $261,241	-9,455 Reduced 44.12%	11,975 $229,000
Q3 2021 Oct 19, 2021	BUY	$20.35 - $26.63 $5,514 - $7,216	271 Added 1.28%	21,430 $528,000
Q2 2021 Jul 16, 2021	BUY	$16.33 - $33.07 $174,877 - $354,146	10,709 Added 102.48%	21,159 $551,000
Q1 2021 Apr 29, 2021	BUY	$28.67 - $52.59 $140,483 - $257,691	4,900 Added 88.29%	10,450 $331,000
Q4 2020 Jan 14, 2021	SELL	$28.04 - $50.26 $34,349 - $61,568	-1,225 Reduced 18.08%	5,550 $258,000
Q3 2020 Oct 15, 2020	SELL	$27.75 - $36.3 $58,275 - $76,230	-2,100 Reduced 23.66%	6,775 $223,000
Q2 2020 Jul 20, 2020	BUY	$27.21 - $41.0 $48,297 - $72,775	1,775 Added 25.0%	8,875 $244,000
Q1 2020 May 04, 2020	BUY	$19.54 - $38.85 $138,734 - $275,835	7,100 New	7,100 $213,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.36B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.